Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (300357.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap14.84B
Enterprise Value14.06B
P/E Ratio25.45
PEG Ratio1.2
Price/Sales Ratio9.74
Price/Book Ratio3.86
Enterprise/Revenue8.95
Enterprise/EBITDA18.92

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.38
Operating Margin0.4
AD

Management Effectiveness

Return On Assets0.14
Return On Equity0.16

Income Statement

Revenue1.06B
Revenue/Share2.09
Gross Profit1.01B
EBITDA489.25M
Net Income380.94M
Diluted EPS0.73

Balance Sheet

Total Cash1.45B
Total Cash/Share2.78
Total Debt18.29M
Total Debt/Equity0.01
Current Ratio9.14
Book Value Per Share5.43

Price History

52-Week Change-29.56
52-Week High35.84
52-Week Low18.65
Moving Average 50 Days22.59
Moving Average 200 Days25

Statistics

Average Volume11.93M
Shares Outstanding523.58M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield1.23
Payout Ratio0.13
Last Split Factor9:5
Last Split DateMay 08, 2019
AD